BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10506715)

  • 1. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: predictors of survival.
    Ragnarsson-Olding BK; Nilsson BR; Kanter-Lewensohn LR; Lagerlöf B; Ringborg UK
    Cancer; 1999 Oct; 86(7):1285-93. PubMed ID: 10506715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical observations and histopathologic features.
    Ragnarsson-Olding BK; Kanter-Lewensohn LR; Lagerlöf B; Nilsson BR; Ringborg UK
    Cancer; 1999 Oct; 86(7):1273-84. PubMed ID: 10506714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
    Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
    Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective population-based study of cutaneous malignant melanoma of the head and neck.
    Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
    Laryngoscope; 2000 Sep; 110(9):1498-504. PubMed ID: 10983950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival analysis of malignant melanoma in Japan--multivariate analysis of prognostic factors.
    Uehara S; Kamo R; Harada T; Ishii M
    Osaka City Med J; 2009 Jun; 55(1):35-52. PubMed ID: 19725433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant melanomas of the vulva].
    Landthaler M; Braun-Falco O; Richter K; Baltzer J; Zander J
    Dtsch Med Wochenschr; 1985 May; 110(20):789-94. PubMed ID: 3996222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
    Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
    Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
    Barnhill RL; Fine JA; Roush GC; Berwick M
    Cancer; 1996 Aug; 78(3):427-32. PubMed ID: 8697387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy and early-stage melanoma.
    Daryanani D; Plukker JT; De Hullu JA; Kuiper H; Nap RE; Hoekstra HJ
    Cancer; 2003 May; 97(9):2248-53. PubMed ID: 12712479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma of the vulva.
    Baltzer J; Kurzl RY; Lohe KJ; Zander J
    J Reprod Med; 1986 Sep; 31(9):825-7. PubMed ID: 3772901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
    Eigentler TK; Buettner PG; Leiter U; Garbe C;
    J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of 42 cases of primary malignant melanoma in female genital tract].
    An JS; Wu LY; Li N; Li B; Yu GZ; Liu LY
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):320-4. PubMed ID: 17673044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
    Sahin S; Rao B; Kopf AW; Lee E; Rigel DS; Nossa R; Rahman IJ; Wortzel H; Marghoob AA; Bart RS
    Cancer; 1997 Oct; 80(8):1426-31. PubMed ID: 9338466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary ano-rectal malignant melanomas within a population-based national patient series in Sweden during 40 years.
    Ragnarsson-Olding BK; Nilsson PJ; Olding LB; Nilsson BR
    Acta Oncol; 2009; 48(1):125-31. PubMed ID: 18607861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of localized melanoma by the exponential survival trees method.
    Huang X; Soong S; McCarthy WH; Urist MM; Balch CM
    Cancer; 1997 Mar; 79(6):1122-8. PubMed ID: 9070489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based incidence rates of malignant melanoma of the vulva in Germany.
    Stang A; Streller B; Eisinger B; Jöckel KH
    Gynecol Oncol; 2005 Jan; 96(1):216-21. PubMed ID: 15589604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V; Breuninger H; Garbe C; Moehrle M
    Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
    Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.